Lack of Neuroprotective Effects of High-Density Lipoprotein Therapy in Stroke under Acute Hyperglycemic Conditions

Introduction: The pleiotropic protective effects of high-density lipoproteins (HDLs) on cerebral ischemia have never been tested under acute hyperglycemic conditions. The aim of this study is to evaluate the potential neuroprotective effect of HDL intracarotid injection in a mouse model of middle ce...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: David Couret, Cynthia Planesse, Jessica Patche, Nicolas Diotel, Brice Nativel, Steeve Bourane, Olivier Meilhac
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/f6a3c4cacb1e4980b54539037d1fa433
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f6a3c4cacb1e4980b54539037d1fa433
record_format dspace
spelling oai:doaj.org-article:f6a3c4cacb1e4980b54539037d1fa4332021-11-11T18:23:35ZLack of Neuroprotective Effects of High-Density Lipoprotein Therapy in Stroke under Acute Hyperglycemic Conditions10.3390/molecules262163651420-3049https://doaj.org/article/f6a3c4cacb1e4980b54539037d1fa4332021-10-01T00:00:00Zhttps://www.mdpi.com/1420-3049/26/21/6365https://doaj.org/toc/1420-3049Introduction: The pleiotropic protective effects of high-density lipoproteins (HDLs) on cerebral ischemia have never been tested under acute hyperglycemic conditions. The aim of this study is to evaluate the potential neuroprotective effect of HDL intracarotid injection in a mouse model of middle cerebral artery occlusion (MCAO) under hyperglycemic conditions. Methods: Forty-two mice were randomized to receive either an intracarotid injection of HDLs or saline. Acute hyperglycemia was induced by an intraperitoneal injection of glucose (2.2 g/kg) 20 min before MCAO. Infarct size (2,3,5-triphenyltetrazolium chloride (TTC)-staining), blood–brain barrier leakage (IgG infiltration), and hemorrhagic changes (hemoglobin assay by ELISA and hemorrhagic transformation score) were analyzed 24 h post-stroke. Brain tissue inflammation (IL-6 by ELISA, neutrophil infiltration and myeloperoxidase by immunohisto-fluorescence) and apoptosis (caspase 3 activation) were also assessed. Results: Intraperitoneal D-glucose injection allowed HDL- and saline-treated groups to reach a blood glucose level of 300 mg/dl in the acute phase of cerebral ischemia. HDL injection did not significantly reduce mortality (19% versus 29% in the saline-injected group) or cerebral infarct size (<i>p</i> = 0.25). Hemorrhagic transformations and inflammation parameters were not different between the two groups. In addition, HDL did not inhibit apoptosis under acute hyperglycemic conditions. <b>Conclusion:</b> We observed a nonsignificant decrease in cerebral infarct size in the HDL group. The deleterious consequences of reperfusion such as hemorrhagic transformation or inflammation were not improved by HDL infusion. In acute hyperglycemia, HDLs are not potent enough to counteract the adverse effects of hyperglycemia. The addition of antioxidants to therapeutic HDLs could improve their neuroprotective capacity.David CouretCynthia PlanesseJessica PatcheNicolas DiotelBrice NativelSteeve BouraneOlivier MeilhacMDPI AGarticlehigh-density lipoproteinstrokeacute hyperglycemiablood–brain barrierhemorrhagic transformationOrganic chemistryQD241-441ENMolecules, Vol 26, Iss 6365, p 6365 (2021)
institution DOAJ
collection DOAJ
language EN
topic high-density lipoprotein
stroke
acute hyperglycemia
blood–brain barrier
hemorrhagic transformation
Organic chemistry
QD241-441
spellingShingle high-density lipoprotein
stroke
acute hyperglycemia
blood–brain barrier
hemorrhagic transformation
Organic chemistry
QD241-441
David Couret
Cynthia Planesse
Jessica Patche
Nicolas Diotel
Brice Nativel
Steeve Bourane
Olivier Meilhac
Lack of Neuroprotective Effects of High-Density Lipoprotein Therapy in Stroke under Acute Hyperglycemic Conditions
description Introduction: The pleiotropic protective effects of high-density lipoproteins (HDLs) on cerebral ischemia have never been tested under acute hyperglycemic conditions. The aim of this study is to evaluate the potential neuroprotective effect of HDL intracarotid injection in a mouse model of middle cerebral artery occlusion (MCAO) under hyperglycemic conditions. Methods: Forty-two mice were randomized to receive either an intracarotid injection of HDLs or saline. Acute hyperglycemia was induced by an intraperitoneal injection of glucose (2.2 g/kg) 20 min before MCAO. Infarct size (2,3,5-triphenyltetrazolium chloride (TTC)-staining), blood–brain barrier leakage (IgG infiltration), and hemorrhagic changes (hemoglobin assay by ELISA and hemorrhagic transformation score) were analyzed 24 h post-stroke. Brain tissue inflammation (IL-6 by ELISA, neutrophil infiltration and myeloperoxidase by immunohisto-fluorescence) and apoptosis (caspase 3 activation) were also assessed. Results: Intraperitoneal D-glucose injection allowed HDL- and saline-treated groups to reach a blood glucose level of 300 mg/dl in the acute phase of cerebral ischemia. HDL injection did not significantly reduce mortality (19% versus 29% in the saline-injected group) or cerebral infarct size (<i>p</i> = 0.25). Hemorrhagic transformations and inflammation parameters were not different between the two groups. In addition, HDL did not inhibit apoptosis under acute hyperglycemic conditions. <b>Conclusion:</b> We observed a nonsignificant decrease in cerebral infarct size in the HDL group. The deleterious consequences of reperfusion such as hemorrhagic transformation or inflammation were not improved by HDL infusion. In acute hyperglycemia, HDLs are not potent enough to counteract the adverse effects of hyperglycemia. The addition of antioxidants to therapeutic HDLs could improve their neuroprotective capacity.
format article
author David Couret
Cynthia Planesse
Jessica Patche
Nicolas Diotel
Brice Nativel
Steeve Bourane
Olivier Meilhac
author_facet David Couret
Cynthia Planesse
Jessica Patche
Nicolas Diotel
Brice Nativel
Steeve Bourane
Olivier Meilhac
author_sort David Couret
title Lack of Neuroprotective Effects of High-Density Lipoprotein Therapy in Stroke under Acute Hyperglycemic Conditions
title_short Lack of Neuroprotective Effects of High-Density Lipoprotein Therapy in Stroke under Acute Hyperglycemic Conditions
title_full Lack of Neuroprotective Effects of High-Density Lipoprotein Therapy in Stroke under Acute Hyperglycemic Conditions
title_fullStr Lack of Neuroprotective Effects of High-Density Lipoprotein Therapy in Stroke under Acute Hyperglycemic Conditions
title_full_unstemmed Lack of Neuroprotective Effects of High-Density Lipoprotein Therapy in Stroke under Acute Hyperglycemic Conditions
title_sort lack of neuroprotective effects of high-density lipoprotein therapy in stroke under acute hyperglycemic conditions
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/f6a3c4cacb1e4980b54539037d1fa433
work_keys_str_mv AT davidcouret lackofneuroprotectiveeffectsofhighdensitylipoproteintherapyinstrokeunderacutehyperglycemicconditions
AT cynthiaplanesse lackofneuroprotectiveeffectsofhighdensitylipoproteintherapyinstrokeunderacutehyperglycemicconditions
AT jessicapatche lackofneuroprotectiveeffectsofhighdensitylipoproteintherapyinstrokeunderacutehyperglycemicconditions
AT nicolasdiotel lackofneuroprotectiveeffectsofhighdensitylipoproteintherapyinstrokeunderacutehyperglycemicconditions
AT bricenativel lackofneuroprotectiveeffectsofhighdensitylipoproteintherapyinstrokeunderacutehyperglycemicconditions
AT steevebourane lackofneuroprotectiveeffectsofhighdensitylipoproteintherapyinstrokeunderacutehyperglycemicconditions
AT oliviermeilhac lackofneuroprotectiveeffectsofhighdensitylipoproteintherapyinstrokeunderacutehyperglycemicconditions
_version_ 1718431858374475776